Ueda H, Harada H, Nozaki M, Katada T, Ui M, Satoh M, Takagi H
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Proc Natl Acad Sci U S A. 1988 Sep;85(18):7013-7. doi: 10.1073/pnas.85.18.7013.
Reconstitution of purified mu opioid receptors with purified guanine nucleotide-binding regulatory proteins (G proteins) was investigated. mu opioid receptors were purified by 6-succinylmorphine AF-AminoTOYOPEARL 650M affinity chromatography and by PBE isoelectric chromatography. The purified mu opioid receptor (pI 5.6) migrated as a single Mr 58,000 polypeptide by NaDodSO4/PAGE, a value identical to that obtained by affinity cross-linking purified mu receptors. When purified mu receptors were reconstituted with purified Gi, the G protein that mediates the inhibition of adenylate cyclase, the displacement of [3H]naloxone (a mu opioid antagonist) binding by [D-Ala2,MePhe4,Gly-ol5]enkephalin (a mu opioid agonist) was increased 215-fold; this increase was abolished by adding 100 microM (guanosine 5'-[gamma-thio]triphosphate. Similar increases in agonist displacement of [3H]naloxone binding (33-fold) and its abolition by guanosine 5'-[gamma-thio]triphosphate were observed with Go, the G protein of unknown function, but not with the v-Ki-ras protein p21. In reconstituted preparations with Gi or Go, neither [D-Pen2,D-Pen5]enkephalin (a delta opioid agonist; where Pen is penicillamine) nor U-69,593 (a kappa opioid agonist) showed displacement of the [3H]naloxone binding. In addition, the mu agonist stimulated both [3H]guanosine 5'-[beta,gamma-imido]triphosphate binding (in exchange for GDP) and the low-Km GTPase in such reconstituted preparations, with Gi and Go but not with the v-Ki-ras protein p21, in a naloxone-reversible manner. The stoichiometry was such that the stimulation of 1 mol of mu receptor led to the binding of [3H]guanosine 5'-[beta,gamma-imido]triphosphate to 2.5 mol of Gi or to 1.37 mol of Go. These results suggest that the purified mu opioid receptor is functionally coupled to Gi and Go in the reconstituted phospholipid vesicles.
研究了用纯化的鸟嘌呤核苷酸结合调节蛋白(G蛋白)对纯化的μ阿片受体进行重组的情况。μ阿片受体通过6-琥珀酰吗啡AF-氨基TOYOPEARL 650M亲和层析和PBE等电层析进行纯化。纯化的μ阿片受体(pI 5.6)在十二烷基硫酸钠/聚丙烯酰胺凝胶电泳(NaDodSO4/PAGE)中迁移为单一的Mr 58,000多肽,该值与通过亲和交联纯化的μ受体获得的值相同。当用纯化的Gi(介导腺苷酸环化酶抑制的G蛋白)对纯化的μ受体进行重组时,[D-Ala2,MePhe4,Gly-ol5]脑啡肽(一种μ阿片激动剂)对[3H]纳洛酮(一种μ阿片拮抗剂)结合的置换增加了215倍;加入100μM鸟苷5'-[γ-硫代]三磷酸可消除这种增加。对于功能未知的G蛋白Go,观察到[3H]纳洛酮结合的激动剂置换也有类似增加(33倍),且被鸟苷5'-[γ-硫代]三磷酸消除,但对于v-Ki-ras蛋白p21则未观察到这种情况。在与Gi或Go重组的制剂中,[D-Pen2,D-Pen5]脑啡肽(一种δ阿片激动剂;其中Pen是青霉胺)和U-69,593(一种κ阿片激动剂)均未显示出对[3H]纳洛酮结合的置换。此外,在这种重组制剂中,μ激动剂以纳洛酮可逆的方式刺激了[3H]鸟苷5'-[β,γ-亚氨基]三磷酸结合(以交换GDP)和低Km GTP酶,该刺激作用在与Gi和Go重组时出现,但与v-Ki-ras蛋白p21重组时未出现。化学计量关系表明,刺激1摩尔μ受体可导致[3H]鸟苷5'-[β,γ-亚氨基]三磷酸与2.5摩尔Gi或1.37摩尔Go结合。这些结果表明,在重组的磷脂囊泡中,纯化的μ阿片受体在功能上与Gi和Go偶联。